► Subscribe to the Financial Times on YouTube: http://bit.ly/FTimeSubs
Sir Andrew Witty, chief executive of GlaxoSmithKline, talks to the FT's pharmaceuticals correspondent Andrew Ward about a challenging past year for the drugmaker and his strategy for returning it to growth.
► FT Business: http://bit.ly/1KUK08s
► UK Business & Politics: http://bit.ly/1AXNyGS
► SABMiller Looks to craft beer for growth: http://bit.ly/1IyNpLK
For more video content from the Financial Times, visit http://www.FT.com/video
Twitter https://twitter.com/ftvideo
Facebook https://www.facebook.com/financialtimes
